Items Tagged ‘GlaxoSmithKline’

October 6, 2009

UPDATE:FDA Panel Unanimously Backs Glaxo Cancer Drug Pazopanib

By Kelley Luckstein

A Food and Drug Administration panel Monday unanimously backed a proposed GlaxoSmithKline PLC (GSK) drug for treating kidney cancer despite agency concerns about a risk of severe liver injury…   But panel members, which included experts in liver injury, said it wasn’t clear if the three deaths were from drug-induced liver injury.   “I think […]

View full entry

Tags: FDA, GlaxoSmithKline, pazopanib